Aspirex™ Thrombectomy System
K-Number: K230356 · 2023-03-31
Device Summary
Frequently Asked Questions
What is the Aspirex™ Thrombectomy System?
Aspirex™ Thrombectomy System is a medical device that received FDA 510(k) clearance on 2023-03-31. The listed applicant is C.R. Bard, Inc.. The 510(k) number is K230356.
When did Aspirex™ Thrombectomy System receive FDA 510(k) clearance?
Aspirex™ Thrombectomy System received FDA 510(k) clearance on 2023-03-31, under 510(k) number K230356.
Who is the listed applicant for Aspirex™ Thrombectomy System?
The FDA 510(k) record lists C.R. Bard, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Aspirex™ Thrombectomy System?
The FDA product code for Aspirex™ Thrombectomy System is QEW.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing C.R. Bard, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: QEW)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.